Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
10.4M
-
Shares change
-
-63.3K
-
Total reported value, excl. options
-
$207M
-
Value change
-
-$1.58M
-
Number of buys
-
24
-
Number of sells
-
-9
-
Price
-
$19.93
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2020
39 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q2 2020.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.4M shares
of 148M outstanding shares and own 7.02% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4M shares), RA CAPITAL MANAGEMENT, L.P. (3.16M shares), WELLINGTON MANAGEMENT GROUP LLP (957K shares), EVENTIDE ASSET MANAGEMENT, LLC (575K shares), VR Adviser, LLC (291K shares), Logos Global Management LP (290K shares), VANGUARD GROUP INC (259K shares), BlackRock Inc. (214K shares), JPMORGAN CHASE & CO (187K shares), and NORTHERN TRUST CORP (81.3K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.